Clinical Trials on Invasive Lobular Carcinoma in Netherlands

Total 1024 results

Bristol-Myers Squibb

Terminated

A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (CheckMate 7G8)

Urinary Bladder Neoplasms

United States, Netherlands, Italy, Argentina, Australia, Austria, Brazil, Canada, Chile, France, Germany, Greece, Israel, Japan, Russian Federation, Spain, Sweden
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma (4CC)

Cholangiocarcinoma

Netherlands
The Netherlands Cancer Institute
Genzyme, a Sanofi Company

Recruiting

Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCLC (RAD-IO)

Carcinoma, Non-Small-Cell Lung

Netherlands
The Netherlands Cancer Institute
Merck Sharp & Dohme LLC; Roche Pharma AG; AstraZeneca

Unknown

Lung Cancer Early Molecular Assessment Trial (LEMA)

Carcinoma, Non-Small-Cell Lung

Netherlands
Erasmus Medical Center

Recruiting

Adrenal Vein Sampling as a Tool to Identify Biomarkers That Aid the Diagnosis of Adrenocortical Carcinoma (AVS for ACC)

Adrenocortical Carcinoma

Netherlands
Erasmus Medical Center

Recruiting

Safely Reduce Cystoscopic Evaluations for Hematuria Patients (SeARCH)

Bladder Cancer | Urothelial Carcinoma | Hematuria | Urothelial Neoplasm

Netherlands
Halozyme Therapeutics

Terminated

A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Carcinoma

Korea, Republic of, United States, Taiwan, United Kingdom, Israel, France, Germany, Netherlands, Canada, Spain, Australia, Brazil, Belgium, Croatia, Czechia, Denmark, Estonia, Hungary, Italy, Latvia, Lithuania, Poland
Academisch Medisch Centrum - Universiteit van Amsterdam...
Noordwest Ziekenhuisgroep

Active, not recruiting

Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab Therapy (BASALT)

Oesophageal Adenocarcinoma | Esophageal Adenocarcinoma | Resectable Carcinoma

Netherlands
Erasmus Medical Center
Maastricht University Medical Center; Catharina Ziekenhuis Eindhoven; Albert... and other collaborators

Unknown

Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol (TopIC-2)

Cervical Intraepithelial Neoplasia

Netherlands
Maastricht Radiation Oncology

Terminated

Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer (Chloroquine)

Small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology
Comprehensive Cancer Centre The Netherlands

Withdrawn

Time Trends in Waiting Times of NSCLC Patients.

Non-Small Cell Lung Cancer

Netherlands
University Medical Center Groningen
Radboud University Medical Center; Maastricht University Medical Center; UMC... and other collaborators

Recruiting

Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield (SERENDIPITY)

Adrenocortical Carcinoma | Adrenal Incidentaloma

Netherlands
The Netherlands Cancer Institute

Completed

Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm. (N12HYB)

Inoperable Locally Advanced Non Small Cell Lung Cancer

Netherlands
Hannah Garcia Garrido

Recruiting

Pneumococcal Vaccination in Patients With Chronic Lymphocytic Leukaemia (Pneumo-CLL)

Pneumococcal Infections | Chronic Lymphocytic Leukemia | Vaccine-Preventable Diseases | Invasive Pneumococcal Disease, Recurrent Isolated

Netherlands
Maastricht University Medical Center

Active, not recruiting

T1 Squamous Cell Carcinomas of the Lip

Recurrence | Surgery | Metastasis | Squamous Cell Carcinoma | Lip | Surgical Margin | Lip Cancer | Lip SCC | Squamous Cell Carcinoma of the Lip | Tumor Free Margins

Netherlands
Radboud University Medical Center

Recruiting

Trained Immunity in Thyroid Carcinoma and Colon Carcinoma

Colon Carcinoma | Thyroid Cancer, Nonmedullary

Netherlands
UMC Utrecht

Unknown

MRI Optimization Study in Stage III NSCLC

Stage III Non-small Cell Lung Cancer

Netherlands
Eli Lilly and Company

Terminated

A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy

Small Cell Lung Cancer | SCLC | Carcinoma, Small Cell

Netherlands, Belgium
Radboud University Medical Center
AstraZeneca

Completed

Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer (Donan)

Non-small Cell Lung Cancer

Netherlands
Radboud University Medical Center
Merck KGaA, Darmstadt, Germany

Completed

PD-L1 Imaging in Non Small Cell Lung Cancer' (PINNACLE) (PINNACLE)

Non Small Cell Lung Cancer

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma (RACCOON)

Perihilar Cholangiocarcinoma

Netherlands
Radboud University Medical Center
Dutch Heart Foundation; Penumbra Inc.

Completed

Dutch Intracerebral Hemorrhage Surgery Trial Pilot Study (DIST pilot)

Intracerebral Hemorrhage | Surgical Procedures, Minimally Invasive

Netherlands
Radboud University Medical Center

Terminated

Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy (IDEAL-VMAT)

Stage III Non-small Cell Lung Cancer | Individualized Radiation Dose Escalation

Netherlands
Maastricht Radiation Oncology
University of Pennsylvania

Completed

State of the Art Photon Therapy Versus Particle Therapy for Small Lung Tumors; a Planning Study Based on a Reference Dataset of Patients (Lung stage I)

Non Small Cell Lung Cancer

Netherlands
Radboud University Medical Center

Unknown

Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors

Renal Cell Carcinoma | Gastrointestinal Stromal Tumor

Netherlands
Amsterdam University Medical Centers (UMC), Location...
Stichting Kinderen Kankervrij (KiKa)

Recruiting

Fluorescence Imaging of the Parathyroid Glands of Children (FLUOPATCH)

Thyroid Diseases | Childhood Thyroid Gland Carcinoma

Netherlands
The Netherlands Cancer Institute
Bristol-Myers Squibb

Recruiting

Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer (NESCIO)

Renal Cell Carcinoma

United Kingdom, Netherlands
Amsterdam UMC, location VUmc
Boehringer Ingelheim

Recruiting

A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer (SHARP)

Advanced Stage Non-small Cell Lung Cancer

Netherlands
European Organisation for Research and Treatment...

Terminated

Sunitinib Malate in Treating Patients With Small Cell Lung Cancer

Lung Cancer

Netherlands
Radboud University Medical Center
Erasmus Medical Center; Leiden University Medical Center; Medical Center Haaglanden and other collaborators

Active, not recruiting

A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck (COMMENCE)

Squamous Cell Carcinoma of the Head and Neck

Netherlands
Erasmus Medical Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Recruiting

Preoperative Radiotherapy in Patients at High Risk of Postoperative Pancreatic Fistula After Pancreatoduodenectomy (FIBROPANC-1)

Pancreatic Fistula | Pancreas Neoplasm | GIST | Neuroendocrine Carcinoma of Pancreas | Duodenum Carcinoma | Distal Cholangiocarcinoma | Pancreas Fibrosis

Netherlands
Maastricht Radiation Oncology

Completed

Usefulness of Blood Biomarkers for Overall Survival in NSCLC

Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Radiotherapy for NSCLC to a Individualized MLD (BRONC MLD)

Non-small Cell Lung Cancer

Netherlands
Amsterdam UMC, location VUmc

Recruiting

[18F]F-AraG PET Imaging to Visualize Tumor Infiltrating T-cell Activation in Non-small Cell Lung Cancer. (ATTAIN)

Non-Small Cell Lung Cancer

Netherlands
Maastricht University
University of California, San Francisco; Centre Hospitalier Universitaire de... and other collaborators

Unknown

Fully Automated Pipeline for the Detection and Segmentation of Non-Small Cell Lung Cancer (NSCLC) on CT Images

Detection | Segmentation

Netherlands
Maastricht Radiation Oncology
National Cancer Institute (NCI); Maastricht University Medical Center

Terminated

Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients (Chloroquine IV)

Small Cell Lung Cancer

Netherlands
Radboud University Medical Center

Completed

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity (LEANDOC)

Breast Cancer | Metastatic Castration-resistant Prostate Carcinoma

Netherlands
Haaglanden Medical Centre
Tata Memorial Centre

Not yet recruiting

Towards Optimal Treatment for High Risk Prostate Cancer (HYPOPRIME)

High Risk Prostate Carcinoma

Netherlands
Amsterdam UMC, location VUmc

Recruiting

Combining Afatinib and Concurrent Chemotherapy, Followed by Osimertinib and Concurrent Chemotherapy, in Untreated EGFR Positive NSCLC Tumors (COMBINATION)

Non-Small Cell Lung Cancer

Netherlands
Radboud University Medical Center
UMC Utrecht; Amsterdam UMC, location VUmc; Maastro Clinic, The Netherlands; Rad...

Completed

Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation Toxicity (UPGRADE-RT)

Head and Neck Neoplasms | Carcinoma, Squamous Cell

Netherlands
Erasmus Medical Center

Recruiting

ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI) (START-TKI)

Non Small Cell Lung Cancer | Liquid Biopsy | Tyrosine Kinase Inhibitor

Netherlands
Janssen Research & Development, LLC

Recruiting

A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) (SunRISe-3)

Bladder Cancer

United States, Belgium, Korea, Republic of, Italy, Taiwan, China, United Kingdom, Germany, France, Argentina, Brazil, Poland, Spain, Japan, Netherlands, India, Canada, Czechia, Mexico, Australia, Portugal
dr. Tom van der Hulle
Leiden University Medical Center

Recruiting

The Pharmacological Effects of Using Cabozantinib With a Light Breakfast (Skippy 1)

Renal Cell Carcinoma

Netherlands
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; Penumbra... and other collaborators

Recruiting

Dutch Intracerebral Hemorrhage Surgery Trial (DIST)

Intracerebral Hemorrhage | Minimally Invasive Surgical Procedures | Endoscopic Surgical Procedures

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Endoscopic Drainage of Presumed Resectable pCCA Using an Intrahepatic Plastic Stent With Retrieval String (CHORDA-II-p)

Perihilar Cholangiocarcinoma

Netherlands
University Medical Center Groningen

Recruiting

Fluorescence Image Guided Surgery in Cholangiocarcinoma (COUGAR)

Hilar Cholangiocarcinoma

Netherlands
Sander van Hootegem

Completed

The Diagnostic Value of Staging Laparoscopy and Computed Tomography Response Assessment in Patients With Gastric Adenocarcinoma

Gastric Cancer

Netherlands
University Medical Center Groningen

Recruiting

Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer (VULCAN)

Non Small Cell Lung Cancer Metastatic

Netherlands
Bayer

Completed

A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants

Healthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 Mutation

Netherlands
Maastricht Radiation Oncology
Anticancer Fund, Belgium; Reliable Cancer Therapies

Terminated

Nitroglycerin in Non-small Cell Lung Cancer (Nitroglycerin)

Non Small Cell Lung Cancer (NSCLC)

Netherlands

Clinical Trials on Invasive Lobular Carcinoma in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations